| Ticker | Company | Zen Rating | Momentum | Price | Volume | Vol 1d % | SMA 10 | SMA 20 | SMA 50 | SMA 100 | SMA 200 | RSI | Stochastic %K | Stochastic %D | StochRSI %K | StochRSI %D | MACD | MACD Signal | MACD Histogram | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPI | OFFICE PROPERTIES INCOME TRUST | $19.00 | 91,000 | -62.55% | 18.49 | 18.22 | N/A | N/A | N/A | 11.90 | 62.48 | 64.41 | N/A | N/A | N/A | N/A | N/A | 2.36 | ||
| IACQ | IRENIC ACQUISITION CORP | $9.93 | 501,000 | 55,566.67% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.08 | ||
| VII | VIKING ACQUISITION CORP II | $9.84 | 3,200 | 39.13% | 9.84 | 9.91 | N/A | N/A | N/A | 22.40 | 13.64 | 16.16 | N/A | N/A | N/A | N/A | N/A | -0.14 | ||
| USDE | STABLECOINX INC | $2.46 | 899,000 | 70.59% | 1.73 | 1.80 | N/A | N/A | N/A | 44.57 | 79.18 | 59.65 | N/A | N/A | N/A | N/A | N/A | 4.31 | ||
| SCTX | SCRIBE THERAPEUTICS INC | $23.80 | 267,000 | 79.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.82 | ||
| APMD | APNIMED INC | $26.51 | 486,000 | 63.09% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.72 | ||
| FRBT | FORBRIGHT INC | $19.51 | 257,000 | 173.40% | 19.65 | 19.57 | N/A | N/A | N/A | 51.67 | 48.40 | 50.13 | 50.36 | 61.21 | N/A | N/A | N/A | 0.10 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.